Circulating follicular helper T cells and subsets are associated with immune response to hepatitis B vaccination-Reference-Cited by-同舟云学术

Circulating follicular helper T cells and subsets are associated with immune response to hepatitis B vaccination

Published:2020-07-02 Issue:2 Volume:17 Page:566-574
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Yin Mingjuan¹²,Xiong Yongzhen³,Huang Lingfeng⁴,Liu Gang⁵,Yu Zuwei⁶,Zhao Yi⁷,Zhao Jie⁸,Zhang Yan⁴,Lian Tingyu⁴,Huang Jingxiao⁴,Liang DongMei⁴,Zeng JinMei⁴,Ni Jindong²⁴

Affiliation:

1. Department of Preventive Medicine, Guangdong Medical University, Dongguan, China

2. Maternal and Child Research Institute, Women and Children’s Hospital Affiliated to Guangdong Medical University (Shunde District Maternal and Child Health Hospital), Foshan, China

3. School Clinic, Guangdong Medical University, Dongguan, China

4. Department of Epidemiology and Biostatistics, Guangdong Medical University, Dongguan, China

5. Department of Immunization Program, Shenzhen Center for Disease Control and Prevention, Shenzhen, China

6. Public Health Office, Dalang Town Community Health Service Center, Dongguan, China

7. Microbiology and Immunology, Guangdong Medical University, Dongguan, China

8. Neonatal Department, Shenzhen Maternal and Child Health Hospital Affiliated to Southern Medical University, Shenzhen, China

Funder

Special Innovation Projects Foundation of the Higher Education Institutions of Guangdong Province

Natural Science Foundation of Guangdong Province

Chinese Foundation for Hepatitis Prevention and Control

Group-type Special Supporting Project for Educational Talents in Universities

Special Innovation Projects Foundation of the Higher Education Institutions of Guangdong Province, China

Science and Technology Planning Project of Guangdong Province

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2020.1775457

Reference37 articles.

1. Access to Treatment for Hepatitis B Virus Infection — Worldwide, 2016

2. WHO. Global Hepatitis Report. 2017:1–83.

3. Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines

4. Diminished Th1 and Th2 Cytokine Production in Healthy Adult Nonresponders to Recombinant Hepatitis B Vaccine

5. Complex cytokine responses to hepatitis B surface antigen and tetanus toxoid in responders, nonresponders and subjects naive to hepatitis B surface antigen

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S100A8 promotes tumor progression by inducing phenotypic polarization of microglia through the TLR4/IL-10 signaling pathway in glioma;Journal of the National Cancer Center;2024-07

2. The role of regulatory T cells and follicular T helper cells in HBV infection;Frontiers in Immunology;2023-05-19

3. Effects of hepatitis B virus infection and strategies for preventing mother-to-child transmission on maternal and fetal T-cell immunity;Frontiers in Immunology;2023-02-16

4. PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages;Journal of Experimental & Clinical Cancer Research;2022-10-14

5. Characterization of the TCR β Chain Repertoire in Peripheral Blood from Hepatitis B Vaccine Responders and Non-Responders;Journal of Inflammation Research;2022-02